3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
5
Waldenstrom Macroglobulinemia
1
Recurrence
1
Precancerous Conditions
1
Neoplasms, Plasma Cell
1
Medulloblastoma
1
Mastocytosis, Systemic
1
Lymphoma, Mantle-Cell
1
Liver Neoplasms
1
Leukemia, Large Granular Lymphocytic
1
Ependymoma
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
7
Biopsy
6
Cyclophosphamide
5
ruxolitinib
4
Mycophenolic Acid
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Tacrolimus
3
Melphalan
3
Injections
3
Decitabine
3
Cyclosporine
3
Azacitidine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
onvansertib
1
merphos
1
iadademstat
1
gilteritinib
1
fedratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Thalidomide
×
1 year
×
Clear all
No trials found.